Very few experiences can be as frightening as receiving a call that your pap smear came back abnormal. Although cervical cancer is the first thing that may comes to mind, most of the time an abnormal pap smear indicates a minor problem with the cervix that may or may not need treatment.
Visit Dr. Indman's award winning web sites: Alternatives in Gynecology and Fibroid Medical Center of Northern California
Very few experiences can be as frightening as receiving a call that your pap smear came back abnormal. Although cervical cancer is the first thing that may comes to mind, most of the time an abnormal pap smear indicates a minor problem with the cervix that may or may not need treatment.
What is the Pap test?
During a pap smear some cells are scraped or brushed off the cervix, and prepared on a slide that can be examined under a microscope. The purpose of the Pap test is to detect changes that may lead to cervical cancer long before cancer develops. Pre-cancer of the cervix is easily treated, and almost always prevents cancer from developing.
Classification of Pap Tests
There have been many classifications of pap tests, leading to a great deal of confusion. It is much simpler to think of the pap smear as showing one of several things:
No matter which classification system is being used, all pap smear reports can be thought of as belonging to one of the above groups.
Years ago pap smears were graded on a scale from 1 to 5, with 1 being normal and 5 being cancer. There was little agreement between labs of what the numbers meant. Although this classification system is obsolete, some labs unfortunately still use this reporting system.
In order to understand how pap tests are classified, you first need to know a little more about the cervix.
Copyright © 1998 Paul D. Indman, M.D.
Copyright © 1998 Paul D. Indman, M.D.
Dostarlimab shows significant survival benefits in endometrial cancer trial
March 21st 2024GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More